3-Methylxanthine
| Title | Journal |
|---|---|
| Effect of decursin on the pharmacokinetics of theophylline and its metabolites in rats. | Journal of ethnopharmacology 20121121 |
| Effect of decursinol angelate on the pharmacokinetics of theophylline and its metabolites in rats. | Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association 20121001 |
| Development and validation of a sensitive LC-MS/MS method for the simultaneous quantitation of theophylline and its metabolites in rat plasma. | Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20120315 |
| The role of transmembrane segment TM3 in the xanthine permease XanQ of Escherichia coli. | The Journal of biological chemistry 20111111 |
| Characterization of a broad-specificity non-haem iron N-demethylase from Pseudomonas putida CBB5 capable of utilizing several purine alkaloids as sole carbon and nitrogen source. | Microbiology (Reading, England) 20110201 |
| Ultrafast dynamics show that the theophylline and 3-methylxanthine aptamers employ a conformational capture mechanism for binding their ligands. | Biochemistry 20100406 |
| Demethylation of theophylline (1,3-dimethylxanthine) to 1-methylxanthine: the first step of an antioxidising cascade. | Redox report : communications in free radical research 20100101 |
| Two distinct pathways for metabolism of theophylline and caffeine are coexpressed in Pseudomonas putida CBB5. | Journal of bacteriology 20090701 |
| A simple HPLC method for the quantification of mizoribine in human serum: pharmacokinetic applications. | Biomedical chromatography : BMC 20081101 |
| Relaxing and contracting effects of theophylline's metabolites on the rabbit upper gastrointestinal tract. | Fundamental & clinical pharmacology 20081001 |
| Anti-inflammatory effect of theophylline in rats and its involvement of the glucocorticoid-glucocorticoid receptor system. | Journal of pharmacological sciences 20080401 |
| Theophylline and its metabolites produce a stimulating cholinergic effect on the small intestine and a nonadrenergic noncholinergic relaxing effect on the colon: a comparative study in the rabbit intestine. | Journal of veterinary pharmacology and therapeutics 20071201 |
| Possible involvement of organic anion and cation transporters in renal excretion of xanthine derivatives, 3-methylxanthine and enprofylline. | Life sciences 20070922 |
| Associations between CYP2E1 promoter polymorphisms and plasma 1,3-dimethyluric acid/theophylline ratios. | European journal of clinical pharmacology 20060801 |
| Towards the design of highly selective recognition sites into molecular imprinting polymers: a computational approach. | Biosensors & bioelectronics 20060715 |
| Liver dysfunction markedly decreases the inhibition of cytochrome P450 1A2-mediated theophylline metabolism by fluvoxamine. | Clinical pharmacology and therapeutics 20060501 |
| Theophylline pharmacokinetics: comparison of Cyp1a1(-/-) and Cyp1a2(-/-) knockout mice, humanized hCYP1A1_1A2 knock-in mice lacking either the mouse Cyp1a1 or Cyp1a2 gene, and Cyp1(+/+) wild-type mice. | Pharmacogenetics and genomics 20050701 |
| Prediction of genotoxicity of chemical compounds by statistical learning methods. | Chemical research in toxicology 20050601 |
| High-throughput liquid chromatography-tandem mass spectrometry assay for plasma theophylline and its metabolites. | Clinical chemistry 20041101 |
| Genetic screens and selections for small molecules based on a synthetic riboswitch that activates protein translation. | Journal of the American Chemical Society 20041020 |
| Separation, pre-concentration, and HPLC analysis of methylxanthines in urine samples. | Journal of separation science 20041001 |
| Catabolism of caffeine in plants and microorganisms. | Frontiers in bioscience : a journal and virtual library 20040501 |
| Biosynthesis, accumulation and degradation of theobromine in developing Theobroma cacao fruits. | Journal of plant physiology 20040401 |
| Group I aptazymes as genetic regulatory switches. | BMC biotechnology 20020101 |
| Structural basis for the binding affinity of xanthines with the DNA intercalator acridine orange. | Journal of medicinal chemistry 20011220 |
| Use of novel solid-phase extraction sorbent materials for high-performance liquid chromatography quantitation of caffeine metabolism products methylxanthines and methyluric acids in samples of biological origin. | Journal of chromatography. B, Biomedical sciences and applications 20010815 |
| Determination of urinary methylated purine pattern by high-performance liquid chromatography. | Journal of chromatography. B, Biomedical sciences and applications 20010210 |
| Theophylline metabolism after cardiac surgery. | Journal of clinical pharmacology 20010201 |
| Caffeine metabolism before and after liver transplantation. | International journal of clinical pharmacology and therapeutics 20010201 |
| Caffeine metabolism in a group of 67 patients with primary biliary cirrhosis. | International journal of clinical pharmacology and therapeutics 20010101 |
| Dose dependent pharmacokinetics of theophylline: Michaelis-Menten parameters for its major metabolic pathways. | European journal of drug metabolism and pharmacokinetics 20010101 |
| Cytochrome P450 isoform selectivity in human hepatic theobromine metabolism. | British journal of clinical pharmacology 19990301 |
| Neurotoxic convulsions induced by theophylline and its metabolites in mice. | Biological & pharmaceutical bulletin 19960601 |
| Structure-activity relationships for the binding of ligands to xanthine or guanine phosphoribosyl-transferase from Toxoplasma gondii. | Biochemical pharmacology 19951109 |
| Synthesis of paraxanthine analogs (1,7-disubstituted xanthines) and other xanthines unsubstituted at the 3-position: structure-activity relationships at adenosine receptors. | Journal of medicinal chemistry 19931029 |
| Kinetics of drug action in disease states. XVI. Pharmacodynamics of theophylline-induced seizures in rats. | The Journal of pharmacology and experimental therapeutics 19860301 |